Skip to main content

Table 1 Patients Characteristics

From: Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy

 

Type 2 diabetic patients

Serum fetuin-A*

  

r

p

n

153

  

Gender (male)

116 (74)§

-

-

Age (Years)

59 ± 8

-0.201#

0.01

BMI (kg/m2)

33 ± 6

-0.125

n.s.

Systolic BP (mmHg)

136 ± 19

0.104

n.s.

Diastolic BP (mmHg)

80 ± 8

0.125

n.s.

Duration of diabetes (years)

12 ± 8

-0.016

n.s.

Current smoker (yes)

25 (16)

-

-

Patients on ACE-inhibitor or angiotensin receptor blocker (yes: n;%)

128 (82)

-

-

Patients on Statin (yes:n;%)

89 (57)

-

-

Patients on Beta-Blockers (yes:n;%)

76 (49)

-

-

Patients receiving antihypertensive drugs (%)

137 (90)

-

-

Patients receiving > 2 antihypertensive drugs (%)

73 (48)

-

-

Patients on Insulin Treatment (yes:n;%)

91 (58)

-

-

HbA1c (%)

7.3 ± 1.2

-0.045

n.s.

Fasting Glucose (mg/dL)

144 ± 50

-0.022

n.s.

Serum Creatinine (mg/dL)

0.89 ± 0.3

0.017

n.s.

Serum Albumin (g/L)

45 ± 3

-0.006

n.s.

Serum Fetuin A (g/L)

0.51 ± 0.17

  
  1. * log transformed data for analysis
  2. # adjusted for gender, all other correlations are partially adjusted for age and gender
  3. § male vs. female: 0.49 ± 0.15 vs. 0.56 ± 0.20 g/L, p = 0.02